Apoptosis was evaluated by counting the percentage of tumor cells that stained positive with an anti-active caspase-3 antibody, as evaluated by IHC analysis of the specimen fixed after incubation in either condition (Figure 7A); 23 ER-positive and seven ER-negative tumors were included in this preclinical study. The gene discussed is CASP3; the disease is neoplasm.